Early convalescent plasma may lower risk of severe COVID in seniors

Plasma in syringes
Jan 06, 2021

Only 16% of those treated developed severe disease, compared with 31% in the placebo group.

Mary Van Beusekom | News Writer | CIDRAP News

Jan 06, 2021
Only 16% of those treated developed severe disease, compared with 31% in the placebo group.Read More

Leave a Reply

Your email address will not be published.